0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vancomycin Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-20N7760
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Vancomycin Market Insights and Forecast to 2028

Global Vancomycin Market Insights and Forecast to 2028

Code: QYRE-Auto-20N7760
Report
May 2022
128 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Vancomycin is an effective and safe antibiotic in the treatment of severe infections caused by methicillin-resistant staphylococcus aureus, methicillin-resistant coagulase-negative staphylococcus and enterococcus, including sepsis, pulmonary infection and skin and soft tissue infection.
Market Analysis and Insights: Global Vancomycin Market

Due to the COVID-19 pandemic, the global Vancomycin market size is estimated to be worth US$ 353.1 million in 2022 and is forecast to a readjusted size of US$ 475.3 million by 2028 with a CAGR of 5.1% during the review period.

Fully considering the economic change by this health crisis, Daptomycin accounting for % of the Vancomycin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Sepsis segment is altered to an % CAGR throughout this forecast period.
China Vancomycin market size is valued at US$ million in 2021, while the US and Europe Vancomycin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Vancomycin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Vancomycin include Pfizer, Eli Lilly and Company, CJ CheilJedang, Xellia Pharmaceuticals ApS, VIANEX, Alchemia Limited, Alvogen, Aphios Corporation and Cellceutix Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Vancomycin Scope and Segment
Vancomycin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Vancomycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Daptomycin
Linezolid
Quinupristin
Ampicillin
Chloramphenicol
Others

Segment by Application

Sepsis
Lung Infection
Skin Soft Tissue Infection
Colitis & Intestinal Inflammation
To Prevent Infection

BY COMPANY

Pfizer
Eli Lilly and Company
CJ CheilJedang
Xellia Pharmaceuticals ApS
VIANEX
Alchemia Limited
Alvogen
Aphios Corporation
Cellceutix Corporation
Enanta Pharmaceuticals
Helix BioMedix
LegoChem Biosciences
Lytix Biopharma
MGB Biopharma Limited
Microbiotix.
MicuRx Pharmaceuticals
Nabriva Therapeutics
NovaBay Pharmaceuticals
NovoBiotic Pharmaceuticals
Oragenics
Sealife Pharma
Taiwan Zhengde Pharmaceutical
Zhejiang Pharmaceutical
Zhejiang Haizheng Pharmaceutical
North China Pharmaceutical
Shenwei Pharmaceutical

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Vancomycin Product Introduction
1.2 Market by Type
1.2.1 Global Vancomycin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Daptomycin
1.2.3 Linezolid
1.2.4 Quinupristin
1.2.5 Ampicillin
1.2.6 Chloramphenicol
1.2.7 Others
1.3 Market by Application
1.3.1 Global Vancomycin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Sepsis
1.3.3 Lung Infection
1.3.4 Skin Soft Tissue Infection
1.3.5 Colitis & Intestinal Inflammation
1.3.6 To Prevent Infection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vancomycin Sales Estimates and Forecasts 2017-2028
2.2 Global Vancomycin Revenue Estimates and Forecasts 2017-2028
2.3 Global Vancomycin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vancomycin Sales by Region
2.4.1 Global Vancomycin Sales by Region (2017-2022)
2.4.2 Global Sales Vancomycin by Region (2023-2028)
2.5 Global Vancomycin Revenue by Region
2.5.1 Global Vancomycin Revenue by Region (2017-2022)
2.5.2 Global Vancomycin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vancomycin Sales by Manufacturers
3.1.1 Global Top Vancomycin Manufacturers by Sales (2017-2022)
3.1.2 Global Vancomycin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vancomycin in 2021
3.2 Global Vancomycin Revenue by Manufacturers
3.2.1 Global Vancomycin Revenue by Manufacturers (2017-2022)
3.2.2 Global Vancomycin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vancomycin Revenue in 2021
3.3 Global Vancomycin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vancomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vancomycin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vancomycin Sales by Type
4.1.1 Global Vancomycin Historical Sales by Type (2017-2022)
4.1.2 Global Vancomycin Forecasted Sales by Type (2023-2028)
4.1.3 Global Vancomycin Sales Market Share by Type (2017-2028)
4.2 Global Vancomycin Revenue by Type
4.2.1 Global Vancomycin Historical Revenue by Type (2017-2022)
4.2.2 Global Vancomycin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vancomycin Revenue Market Share by Type (2017-2028)
4.3 Global Vancomycin Price by Type
4.3.1 Global Vancomycin Price by Type (2017-2022)
4.3.2 Global Vancomycin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vancomycin Sales by Application
5.1.1 Global Vancomycin Historical Sales by Application (2017-2022)
5.1.2 Global Vancomycin Forecasted Sales by Application (2023-2028)
5.1.3 Global Vancomycin Sales Market Share by Application (2017-2028)
5.2 Global Vancomycin Revenue by Application
5.2.1 Global Vancomycin Historical Revenue by Application (2017-2022)
5.2.2 Global Vancomycin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vancomycin Revenue Market Share by Application (2017-2028)
5.3 Global Vancomycin Price by Application
5.3.1 Global Vancomycin Price by Application (2017-2022)
5.3.2 Global Vancomycin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vancomycin Market Size by Type
6.1.1 North America Vancomycin Sales by Type (2017-2028)
6.1.2 North America Vancomycin Revenue by Type (2017-2028)
6.2 North America Vancomycin Market Size by Application
6.2.1 North America Vancomycin Sales by Application (2017-2028)
6.2.2 North America Vancomycin Revenue by Application (2017-2028)
6.3 North America Vancomycin Market Size by Country
6.3.1 North America Vancomycin Sales by Country (2017-2028)
6.3.2 North America Vancomycin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Vancomycin Market Size by Type
7.1.1 Europe Vancomycin Sales by Type (2017-2028)
7.1.2 Europe Vancomycin Revenue by Type (2017-2028)
7.2 Europe Vancomycin Market Size by Application
7.2.1 Europe Vancomycin Sales by Application (2017-2028)
7.2.2 Europe Vancomycin Revenue by Application (2017-2028)
7.3 Europe Vancomycin Market Size by Country
7.3.1 Europe Vancomycin Sales by Country (2017-2028)
7.3.2 Europe Vancomycin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vancomycin Market Size by Type
8.1.1 Asia Pacific Vancomycin Sales by Type (2017-2028)
8.1.2 Asia Pacific Vancomycin Revenue by Type (2017-2028)
8.2 Asia Pacific Vancomycin Market Size by Application
8.2.1 Asia Pacific Vancomycin Sales by Application (2017-2028)
8.2.2 Asia Pacific Vancomycin Revenue by Application (2017-2028)
8.3 Asia Pacific Vancomycin Market Size by Region
8.3.1 Asia Pacific Vancomycin Sales by Region (2017-2028)
8.3.2 Asia Pacific Vancomycin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Vancomycin Market Size by Type
9.1.1 Latin America Vancomycin Sales by Type (2017-2028)
9.1.2 Latin America Vancomycin Revenue by Type (2017-2028)
9.2 Latin America Vancomycin Market Size by Application
9.2.1 Latin America Vancomycin Sales by Application (2017-2028)
9.2.2 Latin America Vancomycin Revenue by Application (2017-2028)
9.3 Latin America Vancomycin Market Size by Country
9.3.1 Latin America Vancomycin Sales by Country (2017-2028)
9.3.2 Latin America Vancomycin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vancomycin Market Size by Type
10.1.1 Middle East and Africa Vancomycin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vancomycin Revenue by Type (2017-2028)
10.2 Middle East and Africa Vancomycin Market Size by Application
10.2.1 Middle East and Africa Vancomycin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vancomycin Revenue by Application (2017-2028)
10.3 Middle East and Africa Vancomycin Market Size by Country
10.3.1 Middle East and Africa Vancomycin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vancomycin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Corporation Information
11.2.2 Eli Lilly and Company Overview
11.2.3 Eli Lilly and Company Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Eli Lilly and Company Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eli Lilly and Company Recent Developments
11.3 CJ CheilJedang
11.3.1 CJ CheilJedang Corporation Information
11.3.2 CJ CheilJedang Overview
11.3.3 CJ CheilJedang Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CJ CheilJedang Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CJ CheilJedang Recent Developments
11.4 Xellia Pharmaceuticals ApS
11.4.1 Xellia Pharmaceuticals ApS Corporation Information
11.4.2 Xellia Pharmaceuticals ApS Overview
11.4.3 Xellia Pharmaceuticals ApS Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Xellia Pharmaceuticals ApS Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Xellia Pharmaceuticals ApS Recent Developments
11.5 VIANEX
11.5.1 VIANEX Corporation Information
11.5.2 VIANEX Overview
11.5.3 VIANEX Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 VIANEX Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 VIANEX Recent Developments
11.6 Alchemia Limited
11.6.1 Alchemia Limited Corporation Information
11.6.2 Alchemia Limited Overview
11.6.3 Alchemia Limited Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Alchemia Limited Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Alchemia Limited Recent Developments
11.7 Alvogen
11.7.1 Alvogen Corporation Information
11.7.2 Alvogen Overview
11.7.3 Alvogen Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Alvogen Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Alvogen Recent Developments
11.8 Aphios Corporation
11.8.1 Aphios Corporation Corporation Information
11.8.2 Aphios Corporation Overview
11.8.3 Aphios Corporation Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Aphios Corporation Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Aphios Corporation Recent Developments
11.9 Cellceutix Corporation
11.9.1 Cellceutix Corporation Corporation Information
11.9.2 Cellceutix Corporation Overview
11.9.3 Cellceutix Corporation Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Cellceutix Corporation Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cellceutix Corporation Recent Developments
11.10 Enanta Pharmaceuticals
11.10.1 Enanta Pharmaceuticals Corporation Information
11.10.2 Enanta Pharmaceuticals Overview
11.10.3 Enanta Pharmaceuticals Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Enanta Pharmaceuticals Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Enanta Pharmaceuticals Recent Developments
11.11 Helix BioMedix
11.11.1 Helix BioMedix Corporation Information
11.11.2 Helix BioMedix Overview
11.11.3 Helix BioMedix Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Helix BioMedix Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Helix BioMedix Recent Developments
11.12 LegoChem Biosciences
11.12.1 LegoChem Biosciences Corporation Information
11.12.2 LegoChem Biosciences Overview
11.12.3 LegoChem Biosciences Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 LegoChem Biosciences Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 LegoChem Biosciences Recent Developments
11.13 Lytix Biopharma
11.13.1 Lytix Biopharma Corporation Information
11.13.2 Lytix Biopharma Overview
11.13.3 Lytix Biopharma Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Lytix Biopharma Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Lytix Biopharma Recent Developments
11.14 MGB Biopharma Limited
11.14.1 MGB Biopharma Limited Corporation Information
11.14.2 MGB Biopharma Limited Overview
11.14.3 MGB Biopharma Limited Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 MGB Biopharma Limited Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 MGB Biopharma Limited Recent Developments
11.15 Microbiotix.
11.15.1 Microbiotix. Corporation Information
11.15.2 Microbiotix. Overview
11.15.3 Microbiotix. Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Microbiotix. Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Microbiotix. Recent Developments
11.16 MicuRx Pharmaceuticals
11.16.1 MicuRx Pharmaceuticals Corporation Information
11.16.2 MicuRx Pharmaceuticals Overview
11.16.3 MicuRx Pharmaceuticals Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 MicuRx Pharmaceuticals Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 MicuRx Pharmaceuticals Recent Developments
11.17 Nabriva Therapeutics
11.17.1 Nabriva Therapeutics Corporation Information
11.17.2 Nabriva Therapeutics Overview
11.17.3 Nabriva Therapeutics Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Nabriva Therapeutics Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Nabriva Therapeutics Recent Developments
11.18 NovaBay Pharmaceuticals
11.18.1 NovaBay Pharmaceuticals Corporation Information
11.18.2 NovaBay Pharmaceuticals Overview
11.18.3 NovaBay Pharmaceuticals Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 NovaBay Pharmaceuticals Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 NovaBay Pharmaceuticals Recent Developments
11.19 NovoBiotic Pharmaceuticals
11.19.1 NovoBiotic Pharmaceuticals Corporation Information
11.19.2 NovoBiotic Pharmaceuticals Overview
11.19.3 NovoBiotic Pharmaceuticals Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 NovoBiotic Pharmaceuticals Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 NovoBiotic Pharmaceuticals Recent Developments
11.20 Oragenics
11.20.1 Oragenics Corporation Information
11.20.2 Oragenics Overview
11.20.3 Oragenics Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Oragenics Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Oragenics Recent Developments
11.21 Sealife Pharma
11.21.1 Sealife Pharma Corporation Information
11.21.2 Sealife Pharma Overview
11.21.3 Sealife Pharma Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Sealife Pharma Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Sealife Pharma Recent Developments
11.22 Taiwan Zhengde Pharmaceutical
11.22.1 Taiwan Zhengde Pharmaceutical Corporation Information
11.22.2 Taiwan Zhengde Pharmaceutical Overview
11.22.3 Taiwan Zhengde Pharmaceutical Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Taiwan Zhengde Pharmaceutical Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Taiwan Zhengde Pharmaceutical Recent Developments
11.23 Zhejiang Pharmaceutical
11.23.1 Zhejiang Pharmaceutical Corporation Information
11.23.2 Zhejiang Pharmaceutical Overview
11.23.3 Zhejiang Pharmaceutical Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Zhejiang Pharmaceutical Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Zhejiang Pharmaceutical Recent Developments
11.24 Zhejiang Haizheng Pharmaceutical
11.24.1 Zhejiang Haizheng Pharmaceutical Corporation Information
11.24.2 Zhejiang Haizheng Pharmaceutical Overview
11.24.3 Zhejiang Haizheng Pharmaceutical Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Zhejiang Haizheng Pharmaceutical Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Zhejiang Haizheng Pharmaceutical Recent Developments
11.25 North China Pharmaceutical
11.25.1 North China Pharmaceutical Corporation Information
11.25.2 North China Pharmaceutical Overview
11.25.3 North China Pharmaceutical Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 North China Pharmaceutical Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 North China Pharmaceutical Recent Developments
11.26 Shenwei Pharmaceutical
11.26.1 Shenwei Pharmaceutical Corporation Information
11.26.2 Shenwei Pharmaceutical Overview
11.26.3 Shenwei Pharmaceutical Vancomycin Sales, Price, Revenue and Gross Margin (2017-2022)
11.26.4 Shenwei Pharmaceutical Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Shenwei Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vancomycin Industry Chain Analysis
12.2 Vancomycin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vancomycin Production Mode & Process
12.4 Vancomycin Sales and Marketing
12.4.1 Vancomycin Sales Channels
12.4.2 Vancomycin Distributors
12.5 Vancomycin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vancomycin Industry Trends
13.2 Vancomycin Market Drivers
13.3 Vancomycin Market Challenges
13.4 Vancomycin Market Restraints
14 Key Findings in The Global Vancomycin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Vancomycin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Daptomycin
    Table 3. Major Manufacturers of Linezolid
    Table 4. Major Manufacturers of Quinupristin
    Table 5. Major Manufacturers of Ampicillin
    Table 6. Major Manufacturers of Chloramphenicol
    Table 7. Major Manufacturers of Others
    Table 8. Global Vancomycin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Vancomycin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Vancomycin Sales by Region (2017-2022) & (KG)
    Table 11. Global Vancomycin Sales Market Share by Region (2017-2022)
    Table 12. Global Vancomycin Sales by Region (2023-2028) & (KG)
    Table 13. Global Vancomycin Sales Market Share by Region (2023-2028)
    Table 14. Global Vancomycin Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Vancomycin Revenue Market Share by Region (2017-2022)
    Table 16. Global Vancomycin Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Vancomycin Revenue Market Share by Region (2023-2028)
    Table 18. Global Vancomycin Sales by Manufacturers (2017-2022) & (KG)
    Table 19. Global Vancomycin Sales Share by Manufacturers (2017-2022)
    Table 20. Global Vancomycin Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Vancomycin Revenue Share by Manufacturers (2017-2022)
    Table 22. Vancomycin Price by Manufacturers (2017-2022) &(US$/G)
    Table 23. Global Vancomycin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Vancomycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vancomycin as of 2021)
    Table 25. Vancomycin Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Vancomycin Product Offered
    Table 27. Date of Manufacturers Enter into Vancomycin Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Vancomycin Sales by Type (2017-2022) & (KG)
    Table 30. Global Vancomycin Sales by Type (2023-2028) & (KG)
    Table 31. Global Vancomycin Sales Share by Type (2017-2022)
    Table 32. Global Vancomycin Sales Share by Type (2023-2028)
    Table 33. Global Vancomycin Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Vancomycin Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Vancomycin Revenue Share by Type (2017-2022)
    Table 36. Global Vancomycin Revenue Share by Type (2023-2028)
    Table 37. Vancomycin Price by Type (2017-2022) & (US$/G)
    Table 38. Global Vancomycin Price Forecast by Type (2023-2028) & (US$/G)
    Table 39. Global Vancomycin Sales by Application (2017-2022) & (KG)
    Table 40. Global Vancomycin Sales by Application (2023-2028) & (KG)
    Table 41. Global Vancomycin Sales Share by Application (2017-2022)
    Table 42. Global Vancomycin Sales Share by Application (2023-2028)
    Table 43. Global Vancomycin Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Vancomycin Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Vancomycin Revenue Share by Application (2017-2022)
    Table 46. Global Vancomycin Revenue Share by Application (2023-2028)
    Table 47. Vancomycin Price by Application (2017-2022) & (US$/G)
    Table 48. Global Vancomycin Price Forecast by Application (2023-2028) & (US$/G)
    Table 49. North America Vancomycin Sales by Type (2017-2022) & (KG)
    Table 50. North America Vancomycin Sales by Type (2023-2028) & (KG)
    Table 51. North America Vancomycin Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Vancomycin Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Vancomycin Sales by Application (2017-2022) & (KG)
    Table 54. North America Vancomycin Sales by Application (2023-2028) & (KG)
    Table 55. North America Vancomycin Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Vancomycin Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Vancomycin Sales by Country (2017-2022) & (KG)
    Table 58. North America Vancomycin Sales by Country (2023-2028) & (KG)
    Table 59. North America Vancomycin Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Vancomycin Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Vancomycin Sales by Type (2017-2022) & (KG)
    Table 62. Europe Vancomycin Sales by Type (2023-2028) & (KG)
    Table 63. Europe Vancomycin Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Vancomycin Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Vancomycin Sales by Application (2017-2022) & (KG)
    Table 66. Europe Vancomycin Sales by Application (2023-2028) & (KG)
    Table 67. Europe Vancomycin Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Vancomycin Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Vancomycin Sales by Country (2017-2022) & (KG)
    Table 70. Europe Vancomycin Sales by Country (2023-2028) & (KG)
    Table 71. Europe Vancomycin Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Vancomycin Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Vancomycin Sales by Type (2017-2022) & (KG)
    Table 74. Asia Pacific Vancomycin Sales by Type (2023-2028) & (KG)
    Table 75. Asia Pacific Vancomycin Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Vancomycin Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Vancomycin Sales by Application (2017-2022) & (KG)
    Table 78. Asia Pacific Vancomycin Sales by Application (2023-2028) & (KG)
    Table 79. Asia Pacific Vancomycin Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Vancomycin Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Vancomycin Sales by Region (2017-2022) & (KG)
    Table 82. Asia Pacific Vancomycin Sales by Region (2023-2028) & (KG)
    Table 83. Asia Pacific Vancomycin Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Vancomycin Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Vancomycin Sales by Type (2017-2022) & (KG)
    Table 86. Latin America Vancomycin Sales by Type (2023-2028) & (KG)
    Table 87. Latin America Vancomycin Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Vancomycin Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Vancomycin Sales by Application (2017-2022) & (KG)
    Table 90. Latin America Vancomycin Sales by Application (2023-2028) & (KG)
    Table 91. Latin America Vancomycin Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Vancomycin Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Vancomycin Sales by Country (2017-2022) & (KG)
    Table 94. Latin America Vancomycin Sales by Country (2023-2028) & (KG)
    Table 95. Latin America Vancomycin Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Vancomycin Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Vancomycin Sales by Type (2017-2022) & (KG)
    Table 98. Middle East and Africa Vancomycin Sales by Type (2023-2028) & (KG)
    Table 99. Middle East and Africa Vancomycin Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Vancomycin Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Vancomycin Sales by Application (2017-2022) & (KG)
    Table 102. Middle East and Africa Vancomycin Sales by Application (2023-2028) & (KG)
    Table 103. Middle East and Africa Vancomycin Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Vancomycin Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Vancomycin Sales by Country (2017-2022) & (KG)
    Table 106. Middle East and Africa Vancomycin Sales by Country (2023-2028) & (KG)
    Table 107. Middle East and Africa Vancomycin Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Vancomycin Revenue by Country (2023-2028) & (US$ Million)
    Table 109. Pfizer Corporation Information
    Table 110. Pfizer Description and Major Businesses
    Table 111. Pfizer Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 112. Pfizer Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Pfizer Recent Developments
    Table 114. Eli Lilly and Company Corporation Information
    Table 115. Eli Lilly and Company Description and Major Businesses
    Table 116. Eli Lilly and Company Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 117. Eli Lilly and Company Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Eli Lilly and Company Recent Developments
    Table 119. CJ CheilJedang Corporation Information
    Table 120. CJ CheilJedang Description and Major Businesses
    Table 121. CJ CheilJedang Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 122. CJ CheilJedang Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. CJ CheilJedang Recent Developments
    Table 124. Xellia Pharmaceuticals ApS Corporation Information
    Table 125. Xellia Pharmaceuticals ApS Description and Major Businesses
    Table 126. Xellia Pharmaceuticals ApS Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 127. Xellia Pharmaceuticals ApS Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Xellia Pharmaceuticals ApS Recent Developments
    Table 129. VIANEX Corporation Information
    Table 130. VIANEX Description and Major Businesses
    Table 131. VIANEX Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 132. VIANEX Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. VIANEX Recent Developments
    Table 134. Alchemia Limited Corporation Information
    Table 135. Alchemia Limited Description and Major Businesses
    Table 136. Alchemia Limited Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 137. Alchemia Limited Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Alchemia Limited Recent Developments
    Table 139. Alvogen Corporation Information
    Table 140. Alvogen Description and Major Businesses
    Table 141. Alvogen Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 142. Alvogen Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Alvogen Recent Developments
    Table 144. Aphios Corporation Corporation Information
    Table 145. Aphios Corporation Description and Major Businesses
    Table 146. Aphios Corporation Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 147. Aphios Corporation Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Aphios Corporation Recent Developments
    Table 149. Cellceutix Corporation Corporation Information
    Table 150. Cellceutix Corporation Description and Major Businesses
    Table 151. Cellceutix Corporation Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 152. Cellceutix Corporation Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Cellceutix Corporation Recent Developments
    Table 154. Enanta Pharmaceuticals Corporation Information
    Table 155. Enanta Pharmaceuticals Description and Major Businesses
    Table 156. Enanta Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 157. Enanta Pharmaceuticals Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Enanta Pharmaceuticals Recent Developments
    Table 159. Helix BioMedix Corporation Information
    Table 160. Helix BioMedix Description and Major Businesses
    Table 161. Helix BioMedix Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 162. Helix BioMedix Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 163. Helix BioMedix Recent Developments
    Table 164. LegoChem Biosciences Corporation Information
    Table 165. LegoChem Biosciences Description and Major Businesses
    Table 166. LegoChem Biosciences Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 167. LegoChem Biosciences Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 168. LegoChem Biosciences Recent Developments
    Table 169. Lytix Biopharma Corporation Information
    Table 170. Lytix Biopharma Description and Major Businesses
    Table 171. Lytix Biopharma Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 172. Lytix Biopharma Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 173. Lytix Biopharma Recent Developments
    Table 174. MGB Biopharma Limited Corporation Information
    Table 175. MGB Biopharma Limited Description and Major Businesses
    Table 176. MGB Biopharma Limited Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 177. MGB Biopharma Limited Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 178. MGB Biopharma Limited Recent Developments
    Table 179. Microbiotix. Corporation Information
    Table 180. Microbiotix. Description and Major Businesses
    Table 181. Microbiotix. Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 182. Microbiotix. Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 183. Microbiotix. Recent Developments
    Table 184. MicuRx Pharmaceuticals Corporation Information
    Table 185. MicuRx Pharmaceuticals Description and Major Businesses
    Table 186. MicuRx Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 187. MicuRx Pharmaceuticals Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 188. MicuRx Pharmaceuticals Recent Developments
    Table 189. Nabriva Therapeutics Corporation Information
    Table 190. Nabriva Therapeutics Description and Major Businesses
    Table 191. Nabriva Therapeutics Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 192. Nabriva Therapeutics Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 193. Nabriva Therapeutics Recent Developments
    Table 194. NovaBay Pharmaceuticals Corporation Information
    Table 195. NovaBay Pharmaceuticals Description and Major Businesses
    Table 196. NovaBay Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 197. NovaBay Pharmaceuticals Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 198. NovaBay Pharmaceuticals Recent Developments
    Table 199. NovoBiotic Pharmaceuticals Corporation Information
    Table 200. NovoBiotic Pharmaceuticals Description and Major Businesses
    Table 201. NovoBiotic Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 202. NovoBiotic Pharmaceuticals Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 203. NovoBiotic Pharmaceuticals Recent Developments
    Table 204. Oragenics Corporation Information
    Table 205. Oragenics Description and Major Businesses
    Table 206. Oragenics Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 207. Oragenics Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 208. Oragenics Recent Developments
    Table 209. Sealife Pharma Corporation Information
    Table 210. Sealife Pharma Description and Major Businesses
    Table 211. Sealife Pharma Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 212. Sealife Pharma Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 213. Sealife Pharma Recent Developments
    Table 214. Taiwan Zhengde Pharmaceutical Corporation Information
    Table 215. Taiwan Zhengde Pharmaceutical Description and Major Businesses
    Table 216. Taiwan Zhengde Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 217. Taiwan Zhengde Pharmaceutical Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 218. Taiwan Zhengde Pharmaceutical Recent Developments
    Table 219. Zhejiang Pharmaceutical Corporation Information
    Table 220. Zhejiang Pharmaceutical Description and Major Businesses
    Table 221. Zhejiang Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 222. Zhejiang Pharmaceutical Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 223. Zhejiang Pharmaceutical Recent Developments
    Table 224. Zhejiang Haizheng Pharmaceutical Corporation Information
    Table 225. Zhejiang Haizheng Pharmaceutical Description and Major Businesses
    Table 226. Zhejiang Haizheng Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 227. Zhejiang Haizheng Pharmaceutical Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 228. Zhejiang Haizheng Pharmaceutical Recent Developments
    Table 229. North China Pharmaceutical Corporation Information
    Table 230. North China Pharmaceutical Description and Major Businesses
    Table 231. North China Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 232. North China Pharmaceutical Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 233. North China Pharmaceutical Recent Developments
    Table 234. Shenwei Pharmaceutical Corporation Information
    Table 235. Shenwei Pharmaceutical Description and Major Businesses
    Table 236. Shenwei Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 237. Shenwei Pharmaceutical Vancomycin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 238. Shenwei Pharmaceutical Recent Developments
    Table 239. Key Raw Materials Lists
    Table 240. Raw Materials Key Suppliers Lists
    Table 241. Vancomycin Distributors List
    Table 242. Vancomycin Customers List
    Table 243. Vancomycin Market Trends
    Table 244. Vancomycin Market Drivers
    Table 245. Vancomycin Market Challenges
    Table 246. Vancomycin Market Restraints
    Table 247. Research Programs/Design for This Report
    Table 248. Key Data Information from Secondary Sources
    Table 249. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vancomycin Product Picture
    Figure 3. Global Vancomycin Market Share by Type in 2021 & 2028
    Figure 3. Daptomycin Product Picture
    Figure 4. Linezolid Product Picture
    Figure 5. Quinupristin Product Picture
    Figure 6. Ampicillin Product Picture
    Figure 7. Chloramphenicol Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Vancomycin Market Share by Application in 2021 & 2028
    Figure 10. Sepsis
    Figure 11. Lung Infection
    Figure 12. Skin Soft Tissue Infection
    Figure 13. Colitis & Intestinal Inflammation
    Figure 14. To Prevent Infection
    Figure 15. Vancomycin Report Years Considered
    Figure 16. Global Vancomycin Sales 2017-2028 (KG)
    Figure 17. Global Vancomycin Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Vancomycin Revenue 2017-2028 (US$ Million)
    Figure 19. Global Vancomycin Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 20. Global Vancomycin Sales Market Share by Region (2017-2022)
    Figure 21. Global Vancomycin Sales Market Share by Region (2023-2028)
    Figure 22. North America Vancomycin Sales YoY (2017-2028) & (KG)
    Figure 23. North America Vancomycin Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Vancomycin Sales YoY (2017-2028) & (KG)
    Figure 25. Europe Vancomycin Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Vancomycin Sales YoY (2017-2028) & (KG)
    Figure 27. Asia-Pacific Vancomycin Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Latin America Vancomycin Sales YoY (2017-2028) & (KG)
    Figure 29. Latin America Vancomycin Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Middle East & Africa Vancomycin Sales YoY (2017-2028) & (KG)
    Figure 31. Middle East & Africa Vancomycin Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. The Vancomycin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 33. The Top 5 and 10 Largest Manufacturers of Vancomycin in the World: Market Share by Vancomycin Revenue in 2021
    Figure 34. Global Vancomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 35. Global Vancomycin Sales Market Share by Type (2017-2028)
    Figure 36. Global Vancomycin Revenue Market Share by Type (2017-2028)
    Figure 37. Global Vancomycin Sales Market Share by Application (2017-2028)
    Figure 38. Global Vancomycin Revenue Market Share by Application (2017-2028)
    Figure 39. North America Vancomycin Sales Market Share by Type (2017-2028)
    Figure 40. North America Vancomycin Revenue Market Share by Type (2017-2028)
    Figure 41. North America Vancomycin Sales Market Share by Application (2017-2028)
    Figure 42. North America Vancomycin Revenue Market Share by Application (2017-2028)
    Figure 43. North America Vancomycin Sales Share by Country (2017-2028)
    Figure 44. North America Vancomycin Revenue Share by Country (2017-2028)
    Figure 45. U.S. Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 46. Canada Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 47. Europe Vancomycin Sales Market Share by Type (2017-2028)
    Figure 48. Europe Vancomycin Revenue Market Share by Type (2017-2028)
    Figure 49. Europe Vancomycin Sales Market Share by Application (2017-2028)
    Figure 50. Europe Vancomycin Revenue Market Share by Application (2017-2028)
    Figure 51. Europe Vancomycin Sales Share by Country (2017-2028)
    Figure 52. Europe Vancomycin Revenue Share by Country (2017-2028)
    Figure 53. Germany Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 54. France Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 55. U.K. Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 56. Italy Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 57. Russia Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 58. Asia Pacific Vancomycin Sales Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Vancomycin Revenue Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Vancomycin Sales Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Vancomycin Revenue Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Vancomycin Sales Share by Region (2017-2028)
    Figure 63. Asia Pacific Vancomycin Revenue Share by Region (2017-2028)
    Figure 64. China Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 65. Japan Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 66. South Korea Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 67. India Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 68. Australia Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 69. Taiwan Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 70. Indonesia Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 71. Thailand Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 72. Malaysia Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 73. Philippines Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 74. Latin America Vancomycin Sales Market Share by Type (2017-2028)
    Figure 75. Latin America Vancomycin Revenue Market Share by Type (2017-2028)
    Figure 76. Latin America Vancomycin Sales Market Share by Application (2017-2028)
    Figure 77. Latin America Vancomycin Revenue Market Share by Application (2017-2028)
    Figure 78. Latin America Vancomycin Sales Share by Country (2017-2028)
    Figure 79. Latin America Vancomycin Revenue Share by Country (2017-2028)
    Figure 80. Mexico Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 81. Brazil Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 82. Argentina Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 83. Middle East and Africa Vancomycin Sales Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Vancomycin Revenue Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Vancomycin Sales Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Vancomycin Revenue Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Vancomycin Sales Share by Country (2017-2028)
    Figure 88. Middle East and Africa Vancomycin Revenue Share by Country (2017-2028)
    Figure 89. Turkey Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 90. Saudi Arabia Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 91. UAE Vancomycin Revenue (2017-2028) & (US$ Million)
    Figure 92. Vancomycin Value Chain
    Figure 93. Vancomycin Production Process
    Figure 94. Channels of Distribution
    Figure 95. Distributors Profiles
    Figure 96. Bottom-up and Top-down Approaches for This Report
    Figure 97. Data Triangulation
    Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network

RELATED REPORTS

Global and United States Sexually Transmitted Disease Therapeutics Market Report Forecast 2022 2028
Global and United States Sexually Transmitted Disease Therapeutics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Othe-412
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Vaccine Technologies Market Report Forecast 2022 2028
Global and United States Vaccine Technologies Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-30Z5715
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Healthcare Acquired Infection Market Report Forecast 2022 2028
Global and United States Healthcare-Acquired Infection Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-24Z5686
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Viral Vector Vaccines Market Report Forecast 2022 2028
Global and United States Viral Vector Vaccines Market Report & Forecast 2022-2028

Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.Market Analysis and Insights Global and United States Viral Vector Vaccines MarketThis report focuses on global and United States Viral Vector Vaccines market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Viral Vector Vaccines market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-30G10233
Tue Jun 07 00:00:00 UTC 2022

Add to Cart